Stockholders' Equity - Additional Information (Details) - USD ($)					12 Months Ended
	Nov. 16, 2022	Jan. 26, 2021	May 22, 2018	Jan. 04, 2017	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jan. 01, 2022	Feb. 28, 2017
Stockholders Equity [Line Items]
Common stock, authorized (in shares)					36,000,000	36,000,000
Preferred stock, authorized (in shares)					25,000,000	25,000,000
Common stock, par value (in dollars per share)					$ 0.001	$ 0.001
Preferred stock, par value (in dollars per share)					$ 0.001	$ 0.001
Common stock, issued (in shares)					30,968,000	27,505,000
Common stock, outstanding (in shares)					30,968,000	27,505,000
Preferred stock, issued (in shares)					0	0
Net proceeds from equity offering after deducting underwriting discounts and commissions and offering expenses					$ 30,774,000	$ 59,525,000
Foreign currency translation adjustments, tax					$ 0	0	$ 700,000
Granted (in USD per share)					$ 15.95
Closing stock price (in USD per share)					$ 12.68
Aggregate intrinsic value, exercised					$ 500,000	6,200,000	1,900,000
Stock Options
Stockholders Equity [Line Items]
Share-based compensation expense					3,200,000	$ 3,700,000	$ 3,200,000
Unrecognized compensation cost related to unvested stock based payments					$ 3,400,000
Unrecognized compensation cost related to unvested stock based payments, weighted average recognition period					2 years
Expected term (years)					6 years 1 month 6 days	6 years	6 years 2 months 12 days
Volatility					58.90%	59.50%	60.50%
Risk free interest rate					1.50%	1.10%	0.40%
Restricted Stock Units
Stockholders Equity [Line Items]
Granted					1,990,000
Share-based compensation expense					$ 11,800,000	$ 4,600,000	$ 1,100,000
Unrecognized compensation cost related to unvested stock based payments					$ 34,000,000
Unrecognized compensation cost related to unvested stock based payments, weighted average recognition period					2 years 6 months
Grant-date fair value of awards granted					$ 31,600,000	22,200,000	4,900,000
Fair value of awards vested					7,400,000	3,100,000	500,000
Employee Stock Purchase Plan (ESPP)
Stockholders Equity [Line Items]
Percentage of outstanding shares			1.00%
Common stock issued or transferred, maximum			2,000,000,000
Shares available for grant			250,000,000
Share-based compensation expense					$ 800,000	$ 700,000	$ 300,000
Percentage of purchase price of shares, lower of the fair market value of common stock			85.00%
Expected term (years)					6 months
Volatility					54.10%
Risk free interest rate					1.40%
Underwriting Agreement | Underwritten Public Offering
Stockholders Equity [Line Items]
Sale of common stock	2,900,000	4,600,000
Common stock, price per share	$ 11.5	$ 14
Gross proceeds from equity offering	$ 33,200,000	$ 64,400,000
Net proceeds from equity offering after deducting underwriting discounts and commissions and offering expenses	$ 30,800,000	$ 59,500,000
Underwriting Agreement | Underwriters’ Option to Purchase Additional Shares
Stockholders Equity [Line Items]
Sale of common stock	400,000	600,000
2017 Plan [Member]
Stockholders Equity [Line Items]
Common stock, authorized (in shares)								1,099,636	1,174,359,000
Common stock, shares reserved for future issuance					5,000,000
Expiration period of options				10 years
Vesting period				4 years
Percentage of outstanding shares				4.00%
Maximum shares granted per individual				4,000,000,000
Maximum cash paid from grants per individual				$ 10,000,000
Common stock issued or transferred, maximum				8,000,000,000
Stock option cancelled					240,792
Incremental expense					$ 0
2017 Plan [Member] | Restricted Stock Units
Stockholders Equity [Line Items]
Granted					120,396
2017 Plan [Member] | Chief Executive Officer
Stockholders Equity [Line Items]
Shares available for grant							518,518
Granted (in USD per share)							$ 10.11
2017 Plan [Member] | 10 percent stockholder
Stockholders Equity [Line Items]
Minimum Stock Option Exercise Price Ten Percent Owners				110.00%
2017 Plan [Member] | Maximum
Stockholders Equity [Line Items]
Expiration period of options				10 years
2017 Plan [Member] | Minimum
Stockholders Equity [Line Items]
Expiration period of options				7 years